Day One Biopharmaceuticals (DAWN) Income Statement (2020 - 2025)
Income Statement report data from Mar 31, 2020 to Dec 31, 2025 for Day One Biopharmaceuticals (DAWN).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | ||||||||||||||||||||||||
Total Revenue | 54M (+34.97%) | 40M (+17.37%) | 34M (+10.24%) | 31M (+5.31%) | 29M (-68.85%) | 94M (+1044.81%) | 8.19M | - | -6.87M | - | 3.41M (-1.73%) | 3.47M | -2.09M | 1.90M (+900.00%) | 190K | - | - | - | - | - | - | - | - | - |
Operating Expenses | ||||||||||||||||||||||||
Research And Development | 41M (+30.33%) | 31M (-13.08%) | 36M (-8.76%) | 40M (-35.91%) | 62M (+84.21%) | 34M (-63.57%) | 92M (+129.07%) | 40M (+7.66%) | 37M (+12.64%) | 33M (+3.05%) | 32M (+15.63%) | 28M (+6.96%) | 26M (+18.06%) | 22M (-2.30%) | 23M (+50.40%) | 15M (+34.05%) | 11M (+13.60%) | 9.85M (-0.61%) | 9.91M (-21.54%) | 13M (+146.20%) | 5.13M (+101.97%) | 2.54M (+76.39%) | 1.44M | - |
Selling General And Administrative | 34M (+21.31%) | 28M (-2.83%) | 29M (-1.23%) | 29M (-1.38%) | 30M (+2.66%) | 29M (-4.04%) | 30M (+13.67%) | 27M (+19.80%) | 22M (+21.35%) | 18M (+7.03%) | 17M (-5.32%) | 18M (+7.83%) | 17M (-5.32%) | 18M (+24.72%) | 14M (+11.06%) | 13M (+18.16%) | 11M (+14.91%) | 9.39M (+69.80%) | 5.53M (+60.29%) | 3.45M (+23.66%) | 2.79M (+173.53%) | 1.02M (+17.24%) | 870K | - |
Operating Expenses | 81M (+26.74%) | 64M (-7.01%) | 69M (-4.11%) | 72M (-24.02%) | 95M (+47.42%) | 64M (-47.86%) | 123M (+84.21%) | 67M (+12.18%) | 60M (+15.71%) | 51M (+4.45%) | 49M (+7.39%) | 46M (+7.30%) | 43M (+7.66%) | 40M (+8.12%) | 37M (+32.32%) | 28M (+26.25%) | 22M (+14.24%) | 19M (+24.61%) | 15M (-4.04%) | 16M (+103.41%) | 7.91M (+122.19%) | 3.56M (+54.11%) | 2.31M | - |
Depreciation And Amortization | 270K | - | - | 90K (+28.57%) | 70K | - | - | 20K (-33.33%) | 30K | - | - | 10K (-83.33%) | 60K | - | - | 10K (-50.00%) | 20K | - | - | 10K (-50.00%) | 20K | - | - | - |
Operating Income | ||||||||||||||||||||||||
Operating Income | -27.46M (+13.24%) | -24.25M (-30.65%) | -34.97M (-14.85%) | -41.07M (-37.13%) | -65.33M | 30M | -114.81M (+71.95%) | -66.77M (+12.18%) | -59.52M (+15.71%) | -51.44M (+4.45%) | -49.25M (+7.42%) | -45.85M (+7.28%) | -42.74M (+7.66%) | -39.70M (+8.12%) | -36.72M (+32.32%) | -27.75M (+26.25%) | -21.98M (+14.24%) | -19.24M (+24.61%) | -15.44M (-4.04%) | -16.09M (+103.41%) | -7.91M (+122.19%) | -3.56M (+54.11%) | -2.31M | - |
Ebit | -27.46M (+13.24%) | -24.25M (-30.65%) | -34.97M (-14.85%) | -41.07M (-37.13%) | -65.33M | 30M | -114.81M (+71.95%) | -66.77M (+12.18%) | -59.52M (+15.71%) | -51.44M (+4.45%) | -49.25M (+7.42%) | -45.85M (+7.28%) | -42.74M (+7.66%) | -39.70M (+8.12%) | -36.72M (+32.32%) | -27.75M (+26.25%) | -21.98M (+14.24%) | -19.24M (+24.61%) | -15.44M (-4.04%) | -16.09M (+152.19%) | -6.38M (+79.21%) | -3.56M (+54.11%) | -2.31M (+50.98%) | -1.53M |
EBITDA | -36.36M (+84.29%) | -19.73M (-34.93%) | -30.32M (-25.99%) | -40.97M (-77.70%) | -183.73M | 36M | -2.85M (-95.73%) | -66.74M (-2.10%) | -68.17M (+47.71%) | -46.15M (+0.63%) | -45.86M (+0.02%) | -45.85M (+2.39%) | -44.78M (+18.50%) | -37.79M (+3.45%) | -36.53M (+31.69%) | -27.74M (+26.44%) | -21.94M (+14.09%) | -19.23M (+24.31%) | -15.47M (-3.79%) | -16.08M (+168.00%) | -6.00M (+56.66%) | -3.83M (+59.58%) | -2.40M (+56.86%) | -1.53M |
Other Income / Expenses | ||||||||||||||||||||||||
Interest Expense | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | -10.00K | 10K (0.00%) | 10K | - | -20.00K | 10K (0.00%) | 10K | - |
Net Interest Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K | -10.00K (0.00%) | -10.00K | - | 20K | -10.00K (0.00%) | -10.00K | - |
Other Non Operating Income | -20.00K (-33.33%) | -30.00K (+50.00%) | -20.00K (0.00%) | -20.00K | 1.22M (+1.67%) | 1.20M | -10.00K (0.00%) | -10.00K (-75.00%) | -40.00K | - | -10.00K | - | -20.00K | 10K | - | - | -10.00K | 10K | -30.00K (+200.00%) | -10.00K (-66.67%) | -30.00K | - | - | - |
Net Income | ||||||||||||||||||||||||
Income Tax Expense | -1.98M | - | - | - | 6.47M | -880.00K | 1.55M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Net Income From Continuing Operations | -21.28M (+7.86%) | -19.73M (-34.93%) | -30.32M (-15.78%) | -36.00M (-45.21%) | -65.71M | 37M | -4.41M (-92.93%) | -62.41M (+14.49%) | -54.51M (+18.11%) | -46.15M (+0.63%) | -45.86M (+8.19%) | -42.39M (+5.68%) | -40.11M (+6.14%) | -37.79M (+3.45%) | -36.53M (+31.64%) | -27.75M (+21.39%) | -22.86M (+18.81%) | -19.24M (+24.37%) | -15.47M (+1.91%) | -15.18M (-53.61%) | -32.72M (+752.08%) | -3.84M (+59.34%) | -2.41M (+57.52%) | -1.53M |
Net Income | -21.28M (+7.86%) | -19.73M (-34.93%) | -30.32M (-15.78%) | -36.00M (-45.21%) | -65.71M | 37M | -4.41M (-92.93%) | -62.41M (+14.49%) | -54.51M (+18.11%) | -46.15M (+0.63%) | -45.86M (+8.19%) | -42.39M (+5.68%) | -40.11M (+6.14%) | -37.79M (+3.45%) | -36.53M (+31.64%) | -27.75M (+21.39%) | -22.86M (+18.81%) | -19.24M (+24.37%) | -15.47M (+1.91%) | -15.18M (-53.61%) | -32.72M (+752.08%) | -3.84M (+59.34%) | -2.41M (+57.52%) | -1.53M |
Comprehensive Income Net Of Tax | -107.34M (+448.49%) | -19.57M (-35.54%) | -30.36M (-15.97%) | -36.13M (-62.14%) | -95.42M | 37M | -4.42M (-92.92%) | -62.43M (-66.94%) | -188.84M (+309.19%) | -46.15M (+0.46%) | -45.94M (+8.73%) | -42.25M (-70.30%) | -142.25M (+272.58%) | -38.18M (+4.52%) | -36.53M (+31.64%) | -27.75M (-61.86%) | -72.75M (+278.12%) | -19.24M (+24.37%) | -15.47M | - | -43.84M | - | - | - |